These results together demonstrated that MT K-Ras is an Hsp90 client protein and Hsp90 may be a novel therapeutic target for K-Ras-dependent colon cancer through a complex formation with p38γ and K-Ras. The gene discussed is HSP90AA1; the disease is colonic neoplasm.